Home Endocrine Regulations 2006 Endocrine Regulations Vol.40, p.53-67, 2006

Journal info

Quarterly, 50 pp. per issue 
Founded: 1967
ISSN 1210-0668
E-ISSN 1336-0329

Published in English

Aims and Scope
Editorial Info
Submission Guidelines

Select Journal

Webshop Cart

Your Cart is currently empty.

Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.

Endocrine Regulations Vol.40, p.53-67, 2006

Author: K. HARISH

Abstract: Thyroglobulin (Tg) measurements in tissue and serum play an important role in the management of differentiated thyroid cancers. In the post thyroid ablation scenario, Tg estimation plays a very important role for detection of recurrence and metastasis. Although there could be Tg autoantibody interference in some patients, Tg is a highly specific and sensitive tumor marker for differentiated thyroid cancer in those where the autoantibody is absent. The clinical sensitivity of Tg is greatest when endogenous TSH is elevated before radioiodine imaging. Tg assays and radioiodine scans are independent indicators of residual or metastatic thyroid cancer, indicating that both these tests are complimentary. Immunohistochemical detection of Tg in surgical specimens is useful in the differential diagnosis of tumors of unknown origin. In future, measurement of Tg mRNA to detect circulating tumor cells may help to overcome some of the current limitations.

Keywords: Thyroglobulin – Serum estimation -Antibodies – mRNA testing - Differentiated thyroid cancer – Radioiodine – Thyroxine – TSH – Diagnostic use
Year: 2006, Volume: 40, Issue: 2 Page From: 53, Page To: 67

Price: 27.00 €

© AEPress s.r.o
Copyright notice: For any permission to reproduce, archive or otherwise use the documents in the ELiS, please contact AEP.